 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Lineage Cell Therapeutics Inc. (LCTX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-07-05 Sale | 2019-07-05 4:32 pm | OncoCyte Corp | OCX | BIOTIME INC 10% Owner | 2,250,000 | $2 | $4,500,000 | 12,424,244 (Direct) | View |
| 2019-08-13 Purchase | 2019-08-15 08:39 am | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M CEO | 10,000 | $1.01 | $10,100 | 84,531 (Direct) | View |
| 2019-08-13 Purchase | 2019-08-15 08:41 am | Lineage Cell Therapeutics Inc. | LCTX | Roberts Brandi CFO | 5,000 | $1.01 | $5,050 | 5,000 (Direct) | View |
| 2019-07-31 Purchase | 2019-08-15 08:42 am | Lineage Cell Therapeutics Inc. | LCTX | Leavitt Chase C. General Counsel/Secretary | 5,000 | $1.02 | $5,100 | 5,000 (Direct) | View |
| 2019-08-13 Purchase | 2019-08-15 7:05 pm | Lineage Cell Therapeutics Inc. | LCTX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C Director 10% Owner | 24,553 | $0.97932 | $24,045 | 34,005,380 (Indirect Direct) | View |
| 2019-09-11 Sale | 2019-09-13 5:20 pm | OncoCyte Corp | OCX | Lineage Cell Therapeutics Inc. 10% Owner | 4,000,000 | $1.66 | $6,640,000 | 8,424,244 (Direct) | View |
| 2020-01-02 Sale | 2020-01-06 5:00 pm | OncoCyte Corp | OCX | Lineage Cell Therapeutics Inc. Previous 10% Owner | 2,383,090 | $2.156 | $5,137,942 | 6,041,154 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2018-12-18 Exercise | 2018-12-20 08:40 am | N/A N/A | BIOTIME INC | BTX | SKIBSTED RUSSELL CFO | 22,500 | $0 | 11,250 (Direct) | View |
| 2018-12-18 Tax Withholding | 2018-12-20 08:40 am | N/A N/A | BIOTIME INC | BTX | SKIBSTED RUSSELL CFO | 7,781 | $1.03 | 11,250 (Direct) | View |
| 2018-12-18 Exercise | 2018-12-20 08:40 am | N/A N/A | BIOTIME INC | BTX | SKIBSTED RUSSELL CFO | 22,500 | $0 | 11,250 (Direct) | View |
| 2019-01-01 Exercise | 2019-01-03 8:35 pm | N/A N/A | BIOTIME INC | BTX | Culley Brian M CEO | 100,000 | $0 | 0 (Direct) | View |
| 2019-01-01 Tax Withholding | 2019-01-03 8:35 pm | N/A N/A | BIOTIME INC | BTX | Culley Brian M CEO | 40,880 | $0.913 | 0 (Direct) | View |
| 2019-01-01 Exercise | 2019-01-03 8:35 pm | N/A N/A | BIOTIME INC | BTX | Culley Brian M CEO | 100,000 | $0 | 0 (Direct) | View |
| 2019-01-07 Option Award | 2019-01-09 8:20 pm | N/A 2029-01-06 | BIOTIME INC | BTX | Roberts Brandi CFO | 500,000 | $1.08 | 500,000 (Direct) | View |
| 2019-03-08 Other | 2019-03-12 4:45 pm | N/A N/A | BIOTIME INC | BTX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C Director 10% Owner | 3,757,430 | $0 | 33,728,992 (Direct) | View |
| 2019-03-08 Other | 2019-03-12 4:45 pm | N/A N/A | BIOTIME INC | BTX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C Director 10% Owner | 0 | $0 | 33,728,992 (Indirect) | View |
| 2019-03-08 Option Award | 2019-03-15 4:49 pm | N/A N/A | BIOTIME INC | BTX | Mulroy Michael H. Director | 194,271 | $0 | 226,821 (Direct) | View |
| 2019-03-19 Option Award | 2019-03-21 7:16 pm | N/A 2029-03-18 | BIOTIME INC | BTX | Wirth Edward Chief Medical Officer | 350,000 | $1.57 | 350,000 (Direct) | View |
| 2019-03-08 Option Award | 2019-04-05 7:10 pm | N/A N/A | BIOTIME INC | BTX | KINGSLEY ALFRED D Director | 6,390 | $0 | 5,457,945 (Direct) | View |
| 2019-04-16 Other | 2019-04-18 6:35 pm | N/A N/A | BIOTIME INC | BTX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C Director 10% Owner | 251,835 | $1.3199 | 33,980,824 (Direct) | View |
| 2019-04-16 Other | 2019-04-18 6:35 pm | N/A N/A | BIOTIME INC | BTX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C Director 10% Owner | 0 | $0 | 33,980,824 (Indirect) | View |
| 2019-05-20 Option Award | 2019-05-22 4:31 pm | N/A 2029-05-19 | BIOTIME INC | BTX | Leavitt Chase C. General Counsel/Secretary | 300,000 | $1.13 | 300,000 (Direct) | View |
| 2019-06-30 Option Award | 2019-07-02 8:14 pm | N/A 2029-06-29 | BIOTIME INC | BTX | Roberts Brandi CFO | 150,000 | $1.1 | 150,000 (Direct) | View |
| 2019-07-01 Option Award | 2019-07-03 5:37 pm | 2019-07-01 2029-06-30 | BIOTIME INC | BTX | BRADSHER NEAL C Director 10% Owner | 40,000 | $1.03 | 40,000 (Direct) | View |
| 2019-07-01 Option Award | 2019-07-03 9:09 pm | N/A 2029-06-30 | BIOTIME INC | BTX | Russell Angus C. Director | 40,000 | $1.03 | 40,000 (Direct) | View |
| 2019-07-01 Option Award | 2019-07-03 9:12 pm | N/A 2029-06-30 | BIOTIME INC | BTX | Mulroy Michael H. Director | 40,000 | $1.03 | 40,000 (Direct) | View |
| 2019-07-01 Option Award | 2019-07-03 9:15 pm | N/A 2029-06-30 | BIOTIME INC | BTX | KINGSLEY ALFRED D Director | 70,000 | $1.03 | 70,000 (Direct) | View |
| 2019-07-01 Option Award | 2019-07-03 9:18 pm | N/A 2029-06-30 | BIOTIME INC | BTX | FARRELL STEPHEN C Director | 40,000 | $1.03 | 40,000 (Direct) | View |
| 2019-03-19 Option Award | 2019-07-03 9:22 pm | N/A 2029-06-30 | BIOTIME INC | BTX | BAILEY DON M Director | 40,000 | $1.03 | 60,000 (Direct) | View |
| 2019-03-19 Option Award | 2019-07-03 9:22 pm | N/A 2029-03-18 | BIOTIME INC | BTX | BAILEY DON M Director | 60,000 | $1.57 | 60,000 (Direct) | View |
| 2019-07-01 Option Award | 2019-07-03 9:25 pm | N/A 2029-06-30 | BIOTIME INC | BTX | ANDREWS DEBORAH J Director | 40,000 | $1.03 | 40,000 (Direct) | View |
| 2019-07-31 Option Award | 2019-08-15 08:42 am | N/A 2029-07-30 | Lineage Cell Therapeutics Inc. | LCTX | Leavitt Chase C. General Counsel/Secretary | 125,000 | $1.1 | 5,000 (Direct) | View |
| 2019-09-17 Exercise | 2019-09-19 5:00 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M CEO | 61,800 | $0 | 185,400 (Direct) | View |
| 2019-09-17 Tax Withholding | 2019-09-19 5:00 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M CEO | 21,371 | $1 | 185,400 (Direct) | View |
| 2019-09-17 Exercise | 2019-09-19 5:00 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M CEO | 61,800 | $0 | 185,400 (Direct) | View |
| 2019-09-30 Exercise | 2019-10-01 5:00 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M CEO | 15,450 | $0 | 169,950 (Direct) | View |
| 2019-09-30 Tax Withholding | 2019-10-01 5:00 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M CEO | 5,343 | $0.98 | 169,950 (Direct) | View |
| 2019-09-30 Exercise | 2019-10-01 5:00 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M CEO | 15,450 | $0 | 169,950 (Direct) | View |
| 2019-12-31 Exercise | 2019-12-31 5:00 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M CEO | 15,450 | $0 | 154,500 (Direct) | View |
| 2019-12-31 Tax Withholding | 2019-12-31 5:00 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M CEO | 5,343 | $0.89 | 154,500 (Direct) | View |
| 2019-12-31 Exercise | 2019-12-31 5:00 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M CEO | 15,450 | $0 | 154,500 (Direct) | View |
| 2020-03-17 Option Award | 2020-03-19 5:00 pm | N/A 2030-03-17 | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M CEO | 1,233,300 | $0.6919 | 1,233,300 (Direct) | View |
| 2020-03-17 Option Award | 2020-03-19 5:00 pm | N/A 2030-03-17 | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. VP | 444,000 | $0.6919 | 444,000 (Direct) | View |
| 2020-03-17 Option Award | 2020-03-19 5:00 pm | N/A 2030-03-17 | Lineage Cell Therapeutics Inc. | LCTX | Leavitt Chase C. General Counsel/Secretary | 616,700 | $0.6919 | 616,700 (Direct) | View |
| 2020-03-17 Option Award | 2020-03-19 5:00 pm | N/A 2030-03-17 | Lineage Cell Therapeutics Inc. | LCTX | Roberts Brandi CFO | 616,700 | $0.6919 | 616,700 (Direct) | View |
| 2020-03-31 Exercise | 2020-03-31 8:00 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M CEO | 15,450 | $0.8281 | 139,050 (Direct) | View |
| 2020-03-31 Tax Withholding | 2020-03-31 8:00 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M CEO | 5,343 | $0.8281 | 139,050 (Direct) | View |
| 2020-03-31 Exercise | 2020-03-31 8:00 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M CEO | 15,450 | $0 | 139,050 (Direct) | View |
| 2020-07-01 Option Award | 2020-07-02 5:00 pm | N/A 2030-07-01 | Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director | 70,000 | $0.8263 | 70,000 (Direct) | View |
| 2020-07-01 Option Award | 2020-07-02 5:01 pm | N/A 2030-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Russell Angus C. Director | 40,000 | $0.8263 | 40,000 (Direct) | View |
| 2020-07-01 Option Award | 2020-07-02 5:02 pm | N/A 2030-07-01 | Lineage Cell Therapeutics Inc. | LCTX | ANDREWS DEBORAH J Director | 40,000 | $0.8263 | 40,000 (Direct) | View |
| 2020-07-01 Option Award | 2020-07-02 5:03 pm | N/A 2030-07-01 | Lineage Cell Therapeutics Inc. | LCTX | BAILEY DON M Director | 40,000 | $0.8263 | 40,000 (Direct) | View |
| 2020-07-01 Option Award | 2020-07-02 5:04 pm | N/A 2030-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Mulroy Michael H. Director | 40,000 | $0.8263 | 40,000 (Direct) | View |
| 2020-07-01 Option Award | 2020-07-02 5:05 pm | N/A 2030-07-01 | Lineage Cell Therapeutics Inc. | LCTX | FARRELL STEPHEN C Director | 40,000 | $0.8263 | 40,000 (Direct) | View |
| 2020-06-30 Exercise | 2020-07-02 5:05 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M CEO | 15,450 | $0.87 | 123,600 (Direct) | View |
| 2020-06-30 Tax Withholding | 2020-07-02 5:05 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M CEO | 5,343 | $0.87 | 123,600 (Direct) | View |
| 2020-06-30 Exercise | 2020-07-02 5:05 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M CEO | 15,450 | $0 | 123,600 (Direct) | View |
| 2020-07-01 Option Award | 2020-07-02 5:14 pm | N/A 2030-07-01 | Lineage Cell Therapeutics Inc. | LCTX | BRADSHER NEAL C Director 10% Owner | 40,000 | $0.8263 | 40,000 (Direct) | View |